Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Neuro-Oncology|July 19, 2015
Isocitrate dehydrogenase mutations in gliomasMatthew S Waitkus, Bill H Diplas, Hai Yan
Cancer Cell|May 29, 2018
Biological Role and Therapeutic Potential of IDH Mutations in CancerMatthew S Waitkus, Bill H Diplas, Hai Yan
Communications Biology|November 10, 2023
Mining cancer genomes for change-of-metabolic-function mutationsKevin J Tu, Bill H Diplas, Joshua A Regal, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2021
SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastomaJacqueline A Brosnan-Cashman, Christine M Davis, Bill H Diplas, et al.
BJR Artificial Intelligence|March 13, 2024
Auto-segmentation of neck nodal metastases using self-distilled masked image transformer on longitudinal MR imagesRamesh Paudyal, Jue Jiang, James Han, et al.
Molecular Cancer Research : MCR|July 12, 2019
CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMPCasey J Moure, Bill H Diplas, Lee H Chen, et al.
Acta Neuropathologica Communications|November 4, 2021
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonistCheng Xu, Heng Liu, Christopher J Pirozzi, et al.
Seminars in Radiation Oncology|March 21, 2022
The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic DiseaseBill H Diplas, Patricia Mae G Santos, Armin Shahrokni, et al.
The Journal of Pathology|April 14, 2016
Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profilesZheming Lu, Jindong Sheng, Yujie Zhang, et al.
Cancer Research|September 26, 2019
Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of <i>ATRX</i>-Mutant Cancers to WEE1 InhibitionJunbo Liang, Hong Zhao, Bill H Diplas, et al.
Pageof 4